Navigation Links
Breast Cancer Advance

With the recent advancements in the field of cancer and our improved understanding of genetic mechanisms behind the development for breast cancer, an effective strategy to treat the disease is not so far // .

The ADAMTS genes are recent additions to a large family known as the metalloproteinases – many of which can break down tissues and have therefore been linked with tumor metastasis, or spread, through the body. Earlier studies have shown that 11 of the 19 ADAMTS genes in humans are significantly altered as breast cancer develops. Latest research now focuses on two of the genes, ADAMTS8 and ADAMTS15, which can help to predict disease outcome in breast cancer patients Differing levels of activity of these genes means that patients can be grouped into one of four categories. These categories could be used to predict the likelihood of the breast cancer recurring. Those in the highest risk category are three times more likely to have a recurrence of breast cancer, and over five times more likely to die from the disease, than patients in the lowest risk category.

It has now been discovered that several 'ADAMTS' genes are turned off in breast cancer compared to normal breast tissue, while others are switched on. These genes could be targets for the development of 'smart' drugs tailored to treat individual patients' tumours. These new findings suggest they could become robust 'markers', predicting disease outcome in breast cancer patients and identifying those patients most at risk of recurrence of the disease. "We are beginning to understand how genes contribute to breast cancer development and I am confident this work will ultimately prove valuable for both diagnosis and treatment of the disease," said Prof Edwards, one of the senior researchers involved.

The spread of breast cancer around the body is the single most important factor in breast cancer mortality. The findings of this research will play a major role in improving the futur
'"/>




Page: 1 2

Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Breast cancer treatment to be determined by gene test
3. Breast Feeding prevents obesity later on in life
4. Breast milk is essential
5. Breast Cancer Surgery Causes Psychological problems
6. Breast cancer evidence
7. Letrozole Beats Tamoxifen in Breast Cancer Therapy
8. Breast screening among diabetic women
9. Breast feeding can alter hormones
10. Diet, Sunlight connected to Breast Cancer Risk
11. Additional Radiotheraphy for Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Breast Cancer Advance

(Date:5/21/2013)... glioblastoma brain tumor cells that uses a modified poliovirus ... establish the proper dose level, researchers at Duke Cancer ... tested in an ongoing phase 1 study, capitalizes on ... receptors that work like magnets drawing the poliovirus, which ... investigational therapy, known as PVSRIPO, uses an engineered form ...
(Date:5/21/2013)... 2013 STAR (Sensory Therapies And ... with sensory challenges and the Sensory Processing Disorder ... and advocacy of Sensory Processing Disorder present Stumbling Blocks ... Improve Quality of Life, a two-hour lecture presented by ... , Learn a method that can aid in ...
(Date:5/21/2013)... As the summer season kicks off, ... camp or beginning practice for summer or fall sports. ... or sporting activities can begin. , To help parents during ... youth sports or camp physicals at just $29. ... review a child’s medical history, perform a physical exam and ...
(Date:5/21/2013)... Diehard soccer fans will definitely want to ... the game between Manchester City and Chelsea FC ... These two teams are highly decorated in the English Premiere ... to the Busch Stadium, home of the St. Louis Cardinals, ... time that a professional sporting event and non-baseball game will ...
(Date:5/21/2013)... 21 (HealthDay News) -- Urban elementary school children ... sleep problems and suffer academically, new research indicates. ... seven to nine, we found that compromised lung ... impaired academic performance," said study author Daphne ... behavior at Brown University,s Alpert Medical School in ...
Breaking Medicine News(10 mins):Health News:Poliovirus vaccine trial shows early promise for recurrent glioblastoma 2Health News:STAR Center and SPD Foundation Present a Lecture on Teens and Adults with Sensory Processing Disorder 2Health News:STAR Center and SPD Foundation Present a Lecture on Teens and Adults with Sensory Processing Disorder 3Health News:MedSpring Offers Affordable Youth Physicals for $29 2Health News:Manchester City vs. Chelsea FC Tickets: Cheap Concert Tickets has Slashed Prices on Manchester City vs. Chelsea FC Tickets at Busch Stadium in St. Louis, MO 2Health News:Sleepless Nights May Hurt School Performance of Kids With Asthma 2
... Christian Davis Furman, M.D., M.S.P.H., vice chair for ... Medicine at the University of Louisville, has been selected ... Innovation Advisors Program. She is the only Kentuckian among ... of Columbia selected to participate. The ...
... New York (CCNY) whose research unites the divergent fields ... honored this month for his pioneering work in biomedical ... photonics. SPIE will present Dr. Robert Alfano, CUNY ... the first annual Britton Chance Biomedical Optics Award January ...
... FRIDAY, Jan. 6 (HealthDay News) -- If you,re 50 or ... screened for colorectal cancer, the American Society for Gastrointestinal Endoscopy ... cancers because most cases arise from precancerous growths in the ... exam and removed before they turn into cancer. Recent ...
... Fla. (Jan. 6, 2012) A malignancy-risk gene signature ... predictive and prognostic value for patients with early stage ... researchers at Moffitt Cancer Center in Tampa, Fla., who ... the Journal of the National Cancer Institute . ...
... Linagliptin (trade name: Trajenta) has been approved since August ... adults with type 2 diabetes mellitus whose elevated blood ... It is an option for patients who do not ... the drug metformin. Moreover, linagliptin can be added if ...
... Reinberg HealthDay Reporter , THURSDAY, Jan. 5 ... U.S. advisory panel,s recommendation to lower the threshold for ... once common in gasoline and house paint, can permanently ... Committee on Childhood Lead Poisoning Prevention voted to recommend ...
Cached Medicine News:Health News:UofL geriatrician selected for new federal Innovation Advisors Program 2Health News:CCNY's Robert Alfano wins first biomedical optics award 2Health News:CCNY's Robert Alfano wins first biomedical optics award 3Health News:Resolve to Take Colon Cancer Test, Experts Say 2Health News:Researchers find malignancy-risk gene signature for early-stage non-small cell lung cancer 2Health News:Added benefit of linagliptin is not proven 2Health News:Experts Endorse Lower Lead-Poisoning Threshold 2Health News:Experts Endorse Lower Lead-Poisoning Threshold 3
(Date:5/21/2013)... , May 21, 2013  IsoRay, Inc. (AMEX: ... that it has entered into an exclusive international distribution ... complete product line in Greece . ... seed brachytherapy and medical radioisotope applications for brain cancer, ... gynecologic ("gyn") cancer. IASIS Medical is ...
(Date:5/21/2013)... 2013 Hurel Corporation ("Hurel"), a world-leading provider ... platforms, today announced the appointment of James ... Board of Directors. Dr. MacDonald is the former Executive ... Institute ("SPRI"), which was the pharmaceutical development arm of ... Co. in 2009. Over a career that ...
(Date:5/21/2013)... BioElectronics Corp. (PINKSHEETS: BIEL), the maker ... that CEO, Andrew J. Whelan ... Advisory Committee, Orthopedic and Rehabilitation Panel compelling arguments ... counter sales. "It,s been 37 years ... schema," Whelan said.  "While the old classification of ...
Breaking Medicine Technology:IsoRay Announces A New International Distributor For Greece 2IsoRay Announces A New International Distributor For Greece 3Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2BioElectronics Presents FDA Reclassification Panel 2BioElectronics Presents FDA Reclassification Panel 3
... Bone strength and heart health are two of the most important ... have an osteoporosis-related fracture in her lifetime and more than 50 ... risk for heart disease. Now there is a new product available ... . Citracal® Calcium plus Heart Health is the first and ...
... RF|Binder Partners today announced that it has been ... ) to help roll out and promote it,s Calmare ... for treating high-intensity oncologic and neuropathic pain, including pain ... is working to expand awareness of the brand and ...
Cached Medicine Technology:Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health, First-Ever Leading Calcium Supplement to Help Support Bone AND Heart Health 2Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health, First-Ever Leading Calcium Supplement to Help Support Bone AND Heart Health 3Competitive Technologies Selects RF|Binder as Public Relations Agency of Record 2Competitive Technologies Selects RF|Binder as Public Relations Agency of Record 3
... The Vitros 950 provides power ... needs of high volume testing ... up to 900 results per ... store and perform the full ...
... Monitoring Market in 1981 with the introduction ... this system uses technology known as FPIA ... concentration in a patient. Therapeutic Drugs, used ... exhibit a narrow therapeutic range requiring close ...
AxSYM Plus provides cutting-edge ergonomics and smart new features that mean increased ease-of-use and enhanced reliability. Also, advanced software means less operator intervention and high-integrit...
Architect i2000SR provides high productivity. Seamless integration optimize performance....
Medicine Products: